Press Releases

All
Smart Stories
All
Press Releases
All
Factsheets

Smart Immune treats adult acute leukemia patient at final dose level in Phase I/II ReSET-02 trial

May 2, 2024

Smart Immune appoints key new members to its Board of Directors

February 16, 2024

Rahim Fandi, M.D, PhD, joins Smart Immune as Chief Medical Officer

December 4, 2023

Smart Immune to host R&D KOL webinar on thymus-empowered ProTcell platform

November 10, 2023

Smart Immune to Present Details of Pioneering Clinical Study at the American Society of Hematology (ASH) Annual Meeting 2023

November 2, 2023

Smart Immune Showcases Data and Presentations at ESGCT

October 12, 2023